Answers are grounded in this paper and cite their sources.
Pharmacokinetics were evaluated for piperacillin given as doses of 15, 30 and 60 mg/kg body weight to 12 healthy volunteers subdivided into three groups which were each given different dosage levels. For the 15, 30 and 60 mg/kg doses, the serum half-lives were 0.8, 1.0 and 0.9 h, and the disposition phase distribution volume coefficients, delta d. beta, 0.31, 0.30, ad 0.25 l/kg. The total body clearances for the three doses normalized to 70 kg body weight were 18.53, 14.00 and 13.53 l/h for the 15, 30 and 60 mg/kg doses, respectively. The corresponding values for the total area under the curves per 1.0 g dose were 57.1, 75.0 and 79.6 micrograms/ml. The urinary elimination of the antibiotic corresponding to the antimicrobial activity of unchanged drug rose from 50.0 to 71.3% of the dose, for a dose increment of 15 to 60 mg/kg. These results document that piperacillin is subject to dose-dependent pharmacokinetics. Capacity-limited kinetics is a property shared by other ureidopenicillins.
No takes yet. Share an insight, caveat, or question.
Bergan et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: